Enzo Biochem (ENZ)

• Market cap: $39.8M
• 1 day: 7.05%
• 5 days: -25.95%
• 1 month: -22.73%
• 3 months: -35.36%
• 6 months: -30.03%
• Year to date: -49.15%
• 1 year: -46.66%
• 5 years: -71.22%
• 10 years: -83.09%
• Sector: Healthcare
• Industry: Medical Laboratories

About: Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Employees: 136

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

10% more funds holding

Funds holding: 39 [Q2] → 43 (+4) [Q3]

4% more capital invested

Capital invested by funds: $13.6M [Q2] → $14.2M (+$597K) [Q3]

0.38% more ownership

Funds ownership: 24.2% [Q2] → 24.58% (+0.38%) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7